Medical Marketing & Media back issues from March 2005:
Transformational thinking.(EDITOR'S DESK)
Mar 01, 2005; ... There are signs everywhere that pharmaceutical marketing is undergoing a transformation. Look at some of the developments of the past month: * The FDA created a new Drug Safety Oversight Board to monitor drugs that already have been approved. The board won't have the authority ...
Reputations are rebuilt by individuals, not CEOs.(Viewpoint)(Brief Article)
Mar 01, 2005; ... "In the Face of Crisis" (MM&M, February 2005) is a well-written "documentary" that provides many with insight into how to handle a potential crisis. It is disappointing, however, to discover that these two behemoths approached the calamity using a basic crisis management model ....
Drug safety criticism the catalyst for change at FDA.(NEWS)(Brief Article)
Mar 01, 2005; ... THE FDA HAS undergone a number of sweeping reforms in response to mounting criticism of its handling of drug safety. As part of its "new vision" initiative, the agency established a new independent Drug Safety Oversight Board to improve the monitoring of medicines already on the ...
Rx sales growth slows up.(prescription drug sales on a high)(Brief Article)
Mar 01, 2005; ... U.S. PRESCRIPTION drug sales in 2004 grew at their slowest rate in nearly a decade, according to data detailing last year's industry performance from IMS Health. Total Rx sales grew sluggishly to $235.4 billion in 2004, up just 8.3 percent from $217.3 billion in 2003, the data ...
U.S. Rx sales, 2005.(IMS INSIGHTS)(retail prescription drug market )(Brief Article)
Mar 01, 2005 ... The U.S. retail prescription drug market grew to $172.2 billion in 2004, up 8.3 percent. Total U.S. prescription drug sales also grew 8.3 percent to $235.4 billion in 2004, compared to $217.3 billion in sales in the previous year. Total prescription growth is 3.3 percent after adjusting ...
Dowden eyes sale to Lebhar-Friedman.(NEWS)
Mar 01, 2005 ... DOWDEN HEALTH Media, publisher of The Journal of Family Practice and Current Psychiatry, was deep into negotiations last month aimed at selling the company to Lebhar-Friedman, a New-York based b-to-b publisher that also is family owned. Carroll Dowden, founder of Dowden in 1988, ...
PhRMA sheds 14 PR firms in review.(public relations )(Brief Article)
Mar 01, 2005; ... PhRMA HAS CUT ties with 14 of the firms handling its state and regional PR as part of a wide-ranging review of its contractors. Ken Johnson, senior vice president, communications, said that while he would not rule out an eventual consolidation, for the moment the group is just ...
Vos named as HBA's Woman of the Year.(NEWS)
Mar 01, 2005; ... THE HEALTHCARE Businesswomen's Association (HBA) has named Lynn O'Connor Vos as its 2005 Woman of the Year. Vos, chief executive of Grey Healthcare Group, founded Phase Five Communications, the med-ed unit of Grey, and serves on a number of industry boards. She is the first ...
Canadian regulators.(Update)
Mar 01, 2005 ... Canadian regulators suspended the sales of Shire's attention deficit ...
Wishbone.(Update)
Mar 01, 2005 ... Wishbone has been named agency of record for Abbott Laboratories' Depakote franchise, following a three-way pitch. Depakote is indicated for ...
Elsevier.(Update)
Mar 01, 2005 ... Elsevier named Andrew McGuire sales manager on The American Journal of Cardiology. McGuire formerly was a senior media planner, advertising operations, at Aventis ....
A Datamonitor report.(Update)
Mar 01, 2005 ... A Datamonitor report in February cited Medsite as the leader in the U.S. e-detailing market. The report noted that ...
Aventis, Novo Nordisk and Roche Diagnostics are among eight inaugural sponsors of dLife, a new TV show and multimedia network targeting people who are living with diabetes.(Update)
Mar 01, 2005 ... Aventis, Novo Nordisk and Roche Diagnostics are among eight inaugural sponsors of dLife, a new TV show ...
Pfizer said its experimental stomach cancer drug, known as SU11248, proved safe and effective in a Phase III study.(Pipeline)
Mar 01, 2005 ... Pfizer said its experimental stomach cancer drug, known as SU11248, proved safe and effective in a Phase III study. The drug, which came with the ...
Mylan Laboratories.(Pipeline)
Mar 01, 2005 ... Mylan Laboratories received approval to market citalopram hydrobromide tablets, the generic version of ...
Roche said its experimental drug designed to raise "good" HDL cholesterol may require two tablets a day.(Pipeline)
Mar 01, 2005 ... Roche said its experimental drug designed to raise "good" HDL cholesterol may require two ...
New River Pharmaceuticals.(Pipeline)
Mar 01, 2005 ... New River Pharmaceuticals will collaborate with Shire to develop and ...
The FDA granted priority review status to Wyeth's NDA.(Pipeline)
Mar 01, 2005 ... The FDA granted priority review status to Wyeth's NDA for its investigational antibiotic Tygacil (tigecycline) ...
ICOS and Solvay Pharmaceuticals.(Pipeline)
Mar 01, 2005 ... ICOS and Solvay Pharmaceuticals will co-market AndroGel testosterone gel as a ...
10 drugs become blockbusters in 2004.(NEWS)
Mar 01, 2005; ... EIGHT PHARMA companies saw their products attain first-time blockbuster status with global sales of $1 billion or more, according to 2004 sales figures from the top 10 drug makers. AstraZeneca and the recently merged Sanofi-Aventis led the pack with two blockbusters each ....
Lilly, Boehringer pull NDA for Yentreve.(Eli Lilly)(Boehringer Ingelheim)(new drug application)(Brief Article)
Mar 01, 2005; ... Eli Lilly and Boehringer Ingelheim withdrew a New Drug Application for Yentreve (duloxetine hydrochloride) as a stress urinary incontinence (SUI) treatment just one day before the FDA was due to submit a reviewof submitted data. The companies, which plan to co-market ...
Drug safety office set for budget hike.(NEWS)
Mar 01, 2005; ... THE BUSH administration in February proposed a 24 percent increase in funding for the FDA's Office of Drug Safety (ODS). The additional $6.5 million would be used in part to hire 25 more employees at the ODS, which currently has a staff of 109. $1.5 million would come from the ...
Antidote.(NEWS)
Mar 01, 2005; ... Pfizer's recent pronouncement that Celebrex has shown no increased overall risk of cardiovascular problems is based upon a massive analysis the company made of 41 completed studies. This finding should come as no surprise. However, what has been missed in the frenzy to make villains of ...
Creative genius Lally dies.(NEWS)(Brief Article)(Obituary)
Mar 01, 2005; ... JOHN LALLY, one of the industry's long-term creative talents, passed away Jan. 22 following a heart attack. He was 68. Lally was a founding partner of Lally, McFarland & Pantello, now a part of the Euro RSCG Life network of healthcare agencies, and was a member of the Medical ...
Medicare cost estimates ignite debate.(NEWS)
Mar 01, 2005; ... NEW ESTIMATES from the Bush administration that the Medicare drug benefit will cost more than $720 billion in its first 10 years--$200 billion more than earlier cost projections indicated--have ignited calls for an inquiry on Capitol Hill. Congressional Democrats argued the ...
As I see it.(Food and Drug Administration's Lester Crawford in controversy)(Brief Article)
Mar 01, 2005; ... FDA acting commissioner Lester Crawford became the focus of new controversy last month when observers learned he was to be nominated for Senate confirmation as commissioner. In 2001, he was passed over in favor of Mark McClellan, primarily because of Senate health committee ...
FDA, CMS to collaborate for faster patient access.(Food and Drug Administration, Department of Health and Human Services. Centers for Medicare and Medicaid Services)(Brief Article)
Mar 01, 2005; ... FDA AND THE Centers for Medicare and Medicaid Services (CMS) have agreed to collaborate more to speed patient access to innovative technologies. The move was announced in January by outgoing Health and Human Services secretary Tommy Thompson as part of an overall department ...
Hatch-Waxman dispute hits high court.(WASHINGTON INSIDER)(Brief Article)
Mar 01, 2005; ... DOES THE 1984 Hatch-Waxman Act research exemption, which allows generic companies to perform research activities with a pioneer's patented product in preparing an ANDA filing, extend to other sponsors' research in discovering new compounds for development? This is a question the ...
Federal judge OKs authorized generics.(marketing of generic drugs)(Brief Article)
Mar 01, 2005 ... A FEDERAL JUDGE agreed with FDA that it has no authority to block "authorized generics" introduced by an innovator in the face of another company's receipt of 180 days' market exclusivity from FDA as the "first" approved generic--contrary to an argument from generic drug maker Teva ...
Graham attacks FDA safety on TV show.(WASHINGTON INSIDER)(Food and Drug Administration)
Mar 01, 2005; ... FDA OFFICE of Drug Safety deputy director David Graham launched a scathing attack of the agency on PBS program Now. Charging FDA with being "oblivious" to drug safety since drug user fees made industry its "client," Graham said that "safety isn't even on the radar screen" and ...
Office of Drug Safety (ODS).(Update)
Mar 01, 2005 ... Ralph Lillie was appointed as acting director of the agency's embattled Office of Drug Safety (ODS) until a "national ...
New Zealand health.(Update)
Mar 01, 2005 ... New Zealand health minister Annette King plans to ban drug DTC ads this year, leaving the U.S. as the only industrialized country with full DTC ...
A professional detail aid for Schering's Foradil Aerolizer 12 mcg broadens its indication and fails to reveal important risk information.(Update)
Mar 01, 2005 ... A professional detail aid for Schering's Foradil Aerolizer 12 mcg broadens its indication and ...
FDA ordered Centocor to add a new warning on hepatotoxicity to the approved labeling for Remicade (inflixamab).(Update)
Mar 01, 2005 ... FDA ordered Centocor to add a new warning on hepatotoxicity to the approved labeling for Remicade (inflixamab) ....
Amgen has been told by FDA to add a class warning to anemia therapy Aranesp's (darbepoetin alfa) labeling about adverse events of similar products..(Update)
Mar 01, 2005 ... Amgen has been told by FDA to add a class warning to anemia therapy Aranesp's (darbepoetin alfa) labeling about adverse events of similar ...
The American Osteopathic Association.(appointment)(Brief Article)
Mar 01, 2005 ... The American Osteopathic Association has hired former Euro RSCG Life media director Tina Menzies as an advertising sales rep. Menzies, who headed media buying and planning for Euro RSCG Life's Robert ...
PERQ/HCI.(Update)
Mar 01, 2005 ... PERQ/HCI has promoted Kathleen Henderson to senior vice president and general manager. Henderson, who has been with the company for 19 years, was ...
Wolters Kluwer Health.(Update)
Mar 01, 2005 ... Wolters Kluwer Health has promoted Dr. Paul Weislogel to executive vice ...
Jobson.(Update)
Mar 01, 2005 ... Jobson has hired Tony Perraglia as associate publisher, Clinician Reviews and Clinician News. Perraglia, who was national accounts manager for Haymarket Medical's Clinical ...
Publicis shifts staff to sister MediaVest.(MEDIA NOTEPAD)(Publicis Healthcare Group)(MediaVest Worldwide)(Brief Article)
Mar 01, 2005; ... PUBLICIS Healthcare Communications Group president and chief operating officer Nick Colucci said the transfer of media personnel to sibling MediaVest was prompted by the growing concentration of media buying assignments for journal advertising into media specialty firms. "For a ...
Former Clinicians execs launch firm.(MEDIA NOTEPAD)
Mar 01, 2005; ... TWO FORMER executives at the Clinicians Group, Dave Mittman and Gary Falcetano, have launched Advance Practice Communications, a sales and consulting firm specializing in titles aimed at nurse practitioners and physician assistants. The company starts out with the sales and marketing ...
Media choice.(American Heart Association's journals)(Brief Article)
Mar 01, 2005; ... Howard Weintraub M.D., Clinical Dir. Lipid Treatment and Research Unit, New York University Medical Center As a noninvasive cardiologist, I value journals that provide a mixture of studies dealing with all aspects of cardiovascular disease. The journal I rely on most is ...
Improving CRM initiatives on the Web.(MEDIA FORUM)
Mar 01, 2005 ... Recent reports indicate that pharma marketers are stepping up spending on Internet-based relationship programs. How do Web ads fit into pharmaceutical CRM initiatives, and can these programs utilize the medium more effectively? Sundeep Bhan Chief executive, ...
Deborah Wood Associates.(Update)
Mar 01, 2005 ... Deborah Wood Associates, a medical education and communication firm in Carmel, Ind., has launched Avant Healthcare Marketing. The new unit will provide ...
Innovia Education Institute.(Update)
Mar 01, 2005 ... Innovia Education Institute, a subsidiary of the Columbia MedCom Group, has tapped Jeffrey Gross and JaNeen Dancy as managers in scientific and ...
Kendle.(Update)
Mar 01, 2005 ... Kendle, a global clinical research organization, has opened an office in New Delhi, India, and tapped Bharat Doshi as its ...
An industry survey.(Update)(Brief Article)
Mar 01, 2005 ... An industry survey found that one-third of respondents expect to increase their allocation for clinical studies training to 17 percent of their total investment in speaker training (from the previous 5 to ...
ACCME posts tools to address new rules.(CME REPORT)
Mar 01, 2005; ... THE ACCREDITATION Council for Continuing Medical Education has rolled out a detailed "toolkit" designed to help the CME community implement the Standards for Commercial Support, which were issued last September. At the time, the standards raised many questions among CME providers, ...
Wicks unit adds Tansey.(CME REPORT)(Michael Tansey)(Wicks Communications and Media Partners)(Brief Article)
Mar 01, 2005 ... WICKS COMMUNICATIONS & Media Partners has selected Michael Tansey as chief executive of its Wicks Medical Information unit. Tansey most recently served as president and chief executive of MedCases, and he held various positions at Thomson Corp. for more than 10 years. "Michael ...
Cadent bolsters its planning team.(CME REPORT)(Cadent Medical Communications)(Brief Article)
Mar 01, 2005 ... CADENT MEDICAL Communications, a medical education unit of inChord Communications, has added four new staff members, including three project coordinators: Kimberly Rozsypal, Valerie Wamsley and Summer Wingard. Irving, Texas-based Cadent also has tapped Chris Brown as a senior ...
Web watch.(E-MARKETING)(Brief Article)
Mar 01, 2005; ... It's no secret that the promotional landscape has changed dramatically over the past few years. New OIG guidelines have changed the way the pharmaceutical industry approaches dinner meetings, symposia, even presentations in hospitals and doctors' offices. One technology gaining popularity ...
Cialis signs sponsorship deal with bass fishermen.(E-MARKETING)(Brief Article)
Mar 01, 2005; ... LILLY ICOS HAS entered into a one-year sponsorship deal with the Bass Anglers Sportsman Society (BASS), the world's largest fishing organization, to give its ED indication Cialis an improved Internet and interactive presence. "BASS members are an important audience to us," said ...
Avenue A/Razorfish absorbs i-Frontier.(E-MARKETING)(Brief Article)
Mar 01, 2005; ... I-FRONTIER, an interactive shop based in Philadelphia, has joined forces with larger sister agency Avenue A/Razorfish and taken on its name as part of a brand unification of the two agencies. The combined entity will represent the digital marketing services business for parent company ...
Dendrite International.(Update)
Mar 01, 2005 ... Dendrite International has signed a comprehensive multi-year services contract with Forest Laboratories to provide help desk services as well as account ...
Xanodyne Pharmaceuticals.(Update)
Mar 01, 2005 ... Xanodyne Pharmaceuticals has launched Target Software's Target Mobile sales effectiveness suite. Xanodyne will use the Target SFA ...
Ventiv Pharma Services.(Update)
Mar 01, 2005 ... Ventiv Pharma Services' Promotech division has launched a mail order pharmacy to provide clients with direct-to-physician and direct-to-patient ...
More money.(marketing investments)(Brief Article)
Mar 01, 2005 ... More money will be spent on direct marketing and sales programs in 2005 than last year, according to the Customer Relationship Management Trends Census conducted by Customer ...
LLKFB reports more top-level changes.(DIRECT MARKETING)
Mar 01, 2005; ... OMNICOM direct communications agency LLKFB has reported another wave of upper-level management changes, including the promotion of one co-founder to its top post and the departure of another. LLKFB co-founder and president Loreen Babcock assumes the title of chairman and chief ...
PreVision hires VIA's Dec.(PreVision Marketing )(Ken Dec)(VIA Group)(Brief Article)
Mar 01, 2005; ... PREVISION, a direct marketing agency in Lincoln, Mass., has hired Ken Dec as chief marketing officer. Dec most recently led strategy and business development at VIA Group, a communications and marketing agency in Boston. "My new job is to build and manage brands and help develop ...
Redi-Mail signs TMS agreement.(DIRECT MARKETING)(TMS Group)(REDI-MAIL Direct Marketing)(Brief Article)
Mar 01, 2005 ... REDI-MAIL Direct Marketing has entered into a partnership deal with TMS Group, a supplier of mail distribution and management, quick copy, digital printing and design and courier services. Under the agreement, Redi-Mail will supply TMS with data processing, cut sheet and ...
Pfizer has named Source Marketing and Chinnici Direct as agencies of record to create consumer ads for glaucoma treatment Xalatan.(Update)
Mar 01, 2005 ... Pfizer has named Source Marketing and Chinnici Direct as agencies of record to create consumer ads for glaucoma ...
Lebhar-Friedman's Consumer Health Publications Group.(Update)
Mar 01, 2005 ... John Tanzola was named national sales manager for Lebhar-Friedman's Consumer Health Publications Group. Tanzola has extensive experience in ...
Pfizer Consumer Healthcare.(Update)
Mar 01, 2005 ... Pfizer Consumer Healthcare division awarded J. Walter Thompson the creative and strategic work ...
The Office of Compliance and Biologics Quality (OCBQ), a unit of the FDA, sent a warning letter to Nabi Pharmaceuticals.(Update)
Mar 01, 2005 ... The Office of Compliance and Biologics Quality (OCBQ), a unit of the FDA, sent a warning letter to Nabi Pharmaceuticals ...
Arnold Worldwide.(Update)
Mar 01, 2005 ... Arnold Worldwide named Susan Polachek senior vice president on the GlaxoSmithKline ...